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Introduction
Hepatocellular carcinoma (HCC) is the sixth most common cancer 
and the second leading cause of all cancer related deaths worldwide [1]. 
According to IARC (2012), 782,000 new cases of HCC are diagnosed 
per year with a mortality rate of 95% (Table 1) [2]. The overall incidence 
in developing countries is five times that of developed nations (513,000 
vs. 110,000) [3]. In United States, the overall incidence rate of HCC 
has been estimated at 2.99 per 100,000 [4,5]. However, for Asian and 
African countries, figures are quite alarming, i.e. about 50-150 cases per 
100,000 [3,6]. Another report suggests approximately 82% incidence 
rate in developing countries, particularly among South Asia with an 
annual incidence of 24 per 100,000 with much greater occurrence in 
the high-risk areas [7,8] (Figure 1 and Table 2). This is because these 
areas have higher risk factors, such as high prevalence of hepatitis B 
and C infections, behavioral factors like obesity, diabetes mellitus, betel 
nutschewing, and an important but largely ignored factor of exposure 
to aflatoxins [8-10].
Aflatoxins are secondary metabolites primarily synthesized by 
food-borne Aspergillus species. Aflatoxins commonly contaminate 
maize, nuts, rice, wheat, and spices like chilies, black pepper, turmeric 
and other food items that are consumed in raw form. Products 
obtained from animals that have ingested contaminated feed are also 
recognized as indirect source.Aflatoxins being highly lipophilic are 
readily absorbed through the gastrointestinal tract. They may also 
enter the bloodstream directly by inhalation [11]. On a global scale, 
approximately 4.5 billion persons living in developing countries are 
frequently exposed to unchecked amounts of the toxin [12] (Table 3). 
Consumption of aflatoxin-contaminated food has been associated with 
HCC [13]. According to a study conducted in 2010, there are 550,000–
600,000 new HCC cases reported and out of those about 25,200–155,000 
may be attributable to aflatoxin exposure [14]. The regions where most 
of these cases occur are sub-Saharan Africa, China, and Southeast Asia; 
areas where the elevated prevalence of viral hepatitis, as well as higher 
occurrence of aflatoxin-contaminated foods, especially the maize 
have been reported [14]. For example in China, reported incidence of 
contamination in corn was 85%, while in Pakistan, reported incidence 
of aflatoxin contamination inmaize was found to be 41.6% and 25% 
in red chillies, respectively [12,15] (Table 4). Both countries have 
significant prevalence of viral hepatitis infections as well [16].
There are many types of aflatoxins (B1, B2, G1, G2 and M1) but 
aflatoxinB1 (AFB1) has been classified as a Group 1 carcinogen 
(definitely carcinogenic to humans) and one of the most potent toxins 
associated with liver cancer [17]. AFB1 metabolites have the ability to 
bind with albumin and the measurement of aflatoxin-serum albumin 
adducts has been used to detect recent exposure in individuals [18-
20]. AFB1 metabolites react with guanine residues in DNA resulting 
in (AFB1)-N7-guanine adducts. A Guanine to Thiamine transversion 
mutation in codon 249 of TP53 gene has been strongly associated with 
aflatoxin exposure and HCC cases [21]. The ability to modulate DNA 
activity by creating such lesions in the DNA may play a role in AFB1 
induced carcinogenesis [22].
There is a significant synergetic effect between aflatoxin and 
Hepatitis B virus (HBV) infection [23]. Another study has associated 
aflatoxin exposure with advanced liver disease in chronic Hepatitis 
C patients [18]. This objective of this article is to emphasize the 
deleterious effects of aflatoxins-contaminated foods and to highlight 
the relationship between aflatoxins and viral associated hepatocellular 
carcinoma. As the proposed findings present a major risk to public 
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Abstract
Hepatocellular carcinoma is a serious human disease with fatal consequences. The most distressing aspect of 
hepatocellular carcinoma is the limited improvement in mortality (mortality rate of more than 90%). At present, the 
underlying molecular mechanisms are not well understood and treatment options are often of limited efficacy. This 
review presents our current understanding of the burden of hepatocellular carcinoma on human health, pathogenesis 
and pathophysiology, and molecular mechanisms associated with the disease, as well as our knowledge of the 
physical barriers, cellular mechanisms and molecular elements that may be targets for therapeutic interventions and/
or the development of preventative measures. As the proposed findings present a major risk to public health, it is 
hoped that robust intervention measures will be introduced for aflatoxins monitoring and reduction in diet.
Region World More developed regions Less developed regions
Cases 782 134 648
Deaths 746 123 622
Percentage (%) 95 92 96
Table 1: Incidence of HCC in the world. There is poor prognosis of HCC, with 
majority of patients expiring within 5 years. The majority of the cases are from less 
developed regions [2].
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health, it is hoped that robust intervention measures will be introduced 
for aflatoxin monitoring and reduction in diet.
Synergism of Aflatoxin and Hepatitis B Viral Infection 
in HCC
HBV and HCC
According to WHO, HBV is the second known carcinogen 
affecting liver after tobacco and there are approximately 350 million 
people chronically infected with HBV worldwide and responsible for 
at least 75% of HCC. In the US, Africa and Europe the prevalence of 
HBV among HCC cases was reported as 9%, 40% and 22%, respectively 
[16]. In Asia, proportion of HBsAg positive HCC cases was greater 
than 50% in China, Taiwan, Korea, Thailand, Vietnam, and Turkey. 
However, for Pakistan and India the prevalence is 30 and 45% 
respectively [16]. The annual risk of HCC is 0.5% for asymptomatic 
HBsAg carriers and 0.8% for patients with chronic hepatitis B [24]. 
Both HBV and HCV can directly lead to HCCreviewed in HBV is 
an oncogenic virus that partially contains double stranded DNA and 
it can directly integrate into the host genome, leading to changes 
in genomic function or chromosomal instability [25]. Of note, the 
integration of HBV DNA into the host genome is not required for 
its replication, however it does allow for the persistence of the viral 
genome within the host. Furthermore, several HBV factors have been 
implicated in hepatocarcinogenesis, including the HBx gene, the pre-
S2/S gene and the HBV spliced protein. By contrast to HBV, HCV 
is a positive-stranded RNA virus. As it lacks reverse transcriptase, it 
cannot integrate into the host genome. Being a completely cytoplasmic 
replicating virus, its involvement in HCC occurs via indirect pathways 
through the effects of chronic inflammation and hepatocellular injury. 
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Figure 1: Number of incidence from 2000-2009.
Year Gender ASR for HCC/ 100,000 in Karachi
1995 - 1997 Males
Females
5.7
3.7
1998 – 2002 Males
Females
5.3
4.0
Year Gender ASR for HCC/ 100,000 in Larkana
2000 – 2002 Males
Females
10.5
2.0
Year Gender ASR for HCC/ 100,000 in Hyderabad
1998 - 2002 Males
Females
4.4
1.2
Year Gender ASR for HCC/ 100,000 in Quetta
1998 - 1999 Males
Females
12.3
3.1
Gender ASR for HCC/ 100,000 in Karachi
1995 - 1997 Males
Females
5.7
3.7
1998 – 2002 Males
Females
5.3
4.0
Year ASR for HCC/ 100,000 in Larkana
2000 – 2002 Males
Females
10.5
2.0
Year ASR for HCC/ 100,000 in Hyderabad
1998 - 2002 Males
Females
4.4
1.2
Year ASR for HCC/ 100,000 in Quetta
1998 - 1999 Males
Females
12.3
3.1
Table 2: Year wise increase in HCC cases with respect to gender in different 
cities of Pakistan. The male to female ratio is 3.6:1.0 [7,61]
Food Product Country
Aflatoxin 
Levels in 
µg/kg
Maximum Allowed 
level according 
to commission 
of European 
Communities. (µg/kg)
Reference
Bread Lebanon 1.12 2.0 [62]
Chocolate Lebanon 4.33 2.0 [63] 
Nuts Lebanon 4.40 8.0 [63]
Rice, wheat, 
Oat, Barley, 
Maize
Malaysia 0.12-4.54 5.0 [64] 
Peanuts Malaysia 0.66-15.33 8.0 [64]
Rice Iran 0.0029 5.0 [65]
Puffed Corn 
Snack Iran 0.0012 8.0 [65] 
Peanuts Iran 0.00154 8.0 [65] 
Bean Iran 0.21-0.29 8.0 [66] 
Maize Iran 30 5.0 [67] 
Peanuts Iran 15 8.0 [67] 
Rice Pakistan 8.5 5.0 [68] 
Corn Pakistan 8 8.0 [68] 
Corn Products Pakistan 5.5 8.0 [68] 
Dried Chili Pakistan Upto 90 5.0 [69] 
Capsicum Pakistan Upto 25 5.0 [70] 
Corn based 
products Indonesia 5.8 – 12.4 8.0 [71] 
Corn Indonesia 119 8.0 [72] 
Corn Phillipines 49 8.0 [73] 
Corn Thailand 63 8.0 [73] 
Maize Taiwan 15 5.0 [67] 
Peanuts Taiwan 15 8.0 [67] 
Rice India <15 5.0 [74] 
Maize India 30 5.0 [67] 
Peanuts India 30 8.0 [67] 
Maize China 40 5.0 [67] 
Peanuts China 49 8.0 [67] 
Nuts and 
Product Japan 0.3-128 8.0 [75] 
Maize Nepal 40 5.0 [67] 
Peanuts Nepal 40 8.0 [67] 
Table 3: Aflatoxin levels in staple food products of different countries in Asia.
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Sampling Region in Pakistan Types of Mycotoxins studied Types of Foodstuffs  Analyzed
No. of Samples 
Analyzed 
Aflatoxins Level
µg/kga
Percentage of 
positive samplesb References
Punjab
aflatoxin B1, total 
aflatoxins and 
ochratoxin A
rice 
corn  
corn products
68
105
102
12.08
5.47
7.85
28
14
20
[68] 
36 districts of Punjab aflatoxin M1
milk
sweet
232
138
0.252
0.58
32
78 [76] 
Across
Pakistan
aflatoxin B1,
B2, G1, G2
paddy rice
parboiled rice
brown rice
white rice
broken rice
58
69
84
93
109
16.35
14.20
9.85
7.10
8.50
64
38
33
42 
50
[40] 
Punjab Aflatxin M1
milk,
yogurt,
white cheese, cheese cream, 
Butter
107
 96 
119 
150
 74 
150.7
90.4
147.8
102.6
69.7
58
47 
15
11
52
[77] 
Faisalabad District  Punjab Aflatxin M1
buffaloes milk,
cows milk,
goats milk,
sheep milk,
camels milk
55 
40
30
24
20  
0.013 
0.014
 0.002
 0.002
 Nil
15.8
20
nil
nil
nil
[78] 
Punjab Aflatoxin B1,B2, G1, G2
Longi chilies
Wonder hot chilies
Skyline 1 chilies
15
12
13
15.91
5.77
12.15
53
8
38
[79] 
Swat Valley
NWFP
Aflatoxin B1ochratoxin 
A
Maize Kernels  upper swat 
Maize Kernels lower swat 
18
18
14.94 
16.22 
66
88 [80] 
Major districts of Punjab 
AflatoxinB1
Aflatoxin M1
halva 
pistachio
almonds
semolina
cardamom
raisins
halva puri
wheat powder
56
71
63
69
34
46
39
53
3.79
9.48
12.98
7.45
2.34
5.34
7.80
5.67
20
23
34
12
11
7
9
11
[81] 
Punjab 4 districts
(Faisalabad, Lahore, Jhang and 
Toba Tek Singh)
aflatoxin B1,
B2, G1, G2
Ochratoxin A
open market:
chilli sauce 
crushed chilli
powdered chilli
Resturant:
chilli sauce 
crushed chilli
powdered chilli
26
29
34
24
28
29
10.4
22.9
27.5
11.3
19.8
21.1
12
27
35
8
32
41
[82] 
NWFP and Northern area of 
Pakistan
aflatoxin B1,
B2, G1, G2
Dried fruits & nuts:
dried apricot, 
dates,
dried figs,
mulberries,
dried raisins,
apricot kernels,
almonds with shells, 
almonds without shells, 
walnuts with shells, 
walnuts without shells,
peanut with shells,
peanuts without shells, 
pistachios with shells, 
pistachios without shells, 
pine nuts with shell,
20
20
10
15
10
15
10
10
10
10
10
10
10
10
10
4.55
2.5
5.81
2.22
5.05
2.65
nil
2.13
6.45
3.43
5.10
5.20
2.10
6.34
3.25
5
nil
30
nil
10
7
nil
nil
20
30
10
20
nil
20
nil
[83] 
Central area of punjab Aflatoxin M1
Winter season & summer 
Raw milk  
UHT milk
Yogurt
Butter
Ice cream
48 & 56 
45 & 39
51 & 45
35 & 35
42 & 37
0.073 & 0.028
0.060 & 0.021
0.053 & 0.019
0.036 & 0.015
0.021 & 0.012
27 & 23
24 & 23
25 & 18
34 & 20
17 & 5
[84] 
Table 4: Natural Aflatoxin occurrence in Pakistani foodstuffs. (aAverage concentration of total aflatoxins where multiple aflatoxins analyzed, otherwise aflatoxin B1 or 
M1; 
bWith respect to EU MRLs)
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In this regard, several HCV proteins, including the core, envelope 
and nonstructural proteinsmay be involved in HCC development via 
oxidative stress, cell cycle control, and tumor formation.
Aflatoxin, HBV and HCC
Studies reveal that South East Asia and Africa show a significant 
overlap between AFB1 exposure and HBV prevalence [14]. According 
to a cohort study by Ming et al., even moderate levels of aflatoxin in diet 
almost tripled the chances of developing HCC in men infected with 
HBV. Another study reported 30 times greater risk of developing HCC 
in individuals co-exposed to both HBV and aflatoxin exposure [26]. In 
comparison to HCV, HBV infection appears to carry a higher risk in 
causing HCC with a 20-fold lower odds ratio for HCV. A mutation at 
249ser-p53 has been identified as a marker to detect concurrent HBV 
infection and aflatoxin exposure. It was found to be present in 54% of 
the HBV positive HCC cases in Oidong, China [27]. While the same 
mutation was found to be absent in 42% matched HCC cases from 
Beijing, known for relatively low aflatoxin exposure [28,29]. Several 
epidemiological studies con¬firm that aflatoxin’s cancer causing 
potency is much greater among HBV-positive than among HBV-
negative individuals [23,27,30]. A strong testimony for the synergistic 
effect of aflatoxin in HBV-associated HCC comes from the fact that 
AFB1 is associated with a G-to-T transversion in codon 249 of the 
TP53 gene which changes arginine to serine. This mutation has been 
seen to interact with HBV X protein in altering cell proliferation and 
chromosome stability of liver cells [31].
Studies on animals have shown that injury to liver cells inflicted 
by HBV can increase the amount of cytochrome p450 in liver cells 
thereby inadvertently increasing aflatoxin metabolism and activation. 
This could also explain why children acutely infected with HBV show 
highest adduct levels, followed by chronic carriers as compared to 
uninfected children [32].
Increased risk of HCC with aflatoxin exposure and 
Hepatitis C Viral infection
HCV and HCC
An earlier report of the World Health Organization suggested that 
approximately 170 million people are chronically infected with HCV 
worldwide [33]. However, considerable regional variations in the 
prevalence of HCV infection in HCC patients is also reported. In the 
US, Africa and Europe, the prevalence of anti- HCVpositiveindividuals 
among HCC cases was 22%, 69% and 45%, respectively. In Asia, majority 
of HCC cases are reported from Japan with 68% sero prevalence of anti-
HCV antibodies. Prevalence of HCV infection in Pakistan is 6.5%with 
a high proportion (45%) of anti-HCV antibodies also detected among 
HCC cases [16,34]. While active HCV RNA infections reported in 
different regions of Pakistan ranged from 3.5-4.9% [35,36].
Aflatoxin, HCV and HCC
Even though aflatoxin and HBV synergism for HCC has been 
reported, similar synergistic effects of aflatoxin in chronic HCV 
infection remain to be settled. A conclusive evidence to this effect is 
hindered by the fact that chronic HCV infection usually occurs later 
in life and persists for a long time, whereas chronic HBV infection 
occurs much earlier, thus it is possible that the time of overlapped 
exposure for aflatoxin and HCV is less significant [14]. An attempt to 
link HCC prevalence and geographical overlap in populations exposed 
to aflatoxin, and populations with a high prevalence of HCV, remained 
inconclusive due to variations encountered in results. For example, 
there was more prevalence of aflatoxin, HCV and HBV in Cameroon 
as compared to Gambia but the latter had higher HCC rates. Perhaps 
this was because of limited data available on HCV prevalence or other 
additional risk factors that were unaccounted for [37]. An association 
between HCV positive patients with Advanced Liver Disease (ALD; 
liver cirrhosis or HCC) and aflatoxin levels has also been reported. 
While ALD patients without anti-HCV positivity revealed no significant 
association with aflatoxin levels. Hence, it can be assumed that ALD 
does not cause increased aflatoxin activation. However, these studies 
did not look at dietary aflatoxin levels [18]. Therefore, investigations on 
associating dietary aflatoxin levels in HCV associated HCC are needed. 
In another study in an HCV-endemic country, the rise in HCC 
cases was strongly linked with food and seeds contaminated with 
aflatoxin. The consumption of aflatoxin contaminated foods was 
assessed and correlated with liver biopsy grade and stage scores of 
chronic HCV patients. It was found that chronic HCV patients who 
had consumed all seven types of aflatoxin contaminated foods were 
positively correlated to grade 3 and stage 3 of liver disease, which is a 
strong precursor for development of HCC [38].
Sun et al., assessed the aflatoxin albumin adduct (AF-alb) levels 
for anti-HCV positive (n=36) and negative (n=406) subjects in a case 
control study in Taiwan. They found that anti-HCV positive subjects 
had less AF-alb detection rates (30.6%) as compared to anti-HCV 
negative subjects (41.6%). This could possibly be because of low sample 
size for anti-HCV positive subjects [39].
Generally, during chronic HCV infection about 10-20% of the 
infected population develops cirrhosis and out of those about 1-4% 
develop HCC. However, in Asian populations, a much higher percentage 
(approximately 20%) of chronic HCV infections are resulting in HCC 
(Figure 2). As increased prevalence of aflatoxin contaminated foods has 
been reported in these areas [14], this brings us to wonder whether 
AFB1 could be acting as a co- carcinogen. In Pakistan, rice is a major 
contributor to the dietary intake of aflatoxins. The total estimated 
amount of aflatoxin intake for average rice consumers ranged from 
19.1 to 26.6 ng/kg body weight/day, which is much higher than the 
reference value of 1 ng/kg body weight/day [40].
Oncogene activation by HCV, could aflatoxins exacerbate it?
HCV enhances the transcription of c-myc oncogene which may 
contribute to the development of cancer [41]. The non-structural 
protein, NS4B is known to transform NIH3T3 cells in association with 
Ha-ras oncogene [42]. NS4B also causes upregulation of RAP1 and 
FYN oncogenes in HeLa cells [43].
In a study in Taiwan, aflatoxin levels were determined in serum 
as well as plasma of the same patients and these samples were then 
tested for p53 mutations and p16 methylation. These two markers are 
indicative of cancer development, p53 beingone of the most frequently 
mutated genes. A significant correlation between aflatoxin adducts, 
p53 mutation and p16 methylation was observed [44]. Another study 
has reported the ability of AFB1 epoxide form to cause mutations in 
human Ha-ras proto-oncogene in vitro [45].
Reactive Oxygen species (ROS) in HCV and role of aflatoxin 
as an agent of oxidative stress
During HCV infection, the production of ROS is enhanced as 
mitochondrial function is impaired, at the same time liver antioxidant 
system is affected leading to aggravated oxidative stress [46]. The 
envelope protein, E2, of HCV has been implicated in upregulation 
of collagen α(1) and oxidative stress in Huh7 cells [47]. Another viral 
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HCV
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other causes.
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Figure 2: Details of chronic HCV infection.
protein, core protein,has been observed to interact with heat shock 
protein Hsp60, a stress protein chaperon. This interaction increases 
ROS production, which upregulates TNF-α-induced apoptotic cell 
deathin Huh7 cells [48].
Exposure to Aflatoxin G1 revealed induction of oxidative stress 
by increasing ROS generation and causing DNA double-strand 
breaks which was reduced upon treatment with anti-oxidants [49]. 
Interestingly, vitamin A, C and E exhibited a protective effect in fresh 
lymphocytes isolated from human blood by inhibiting ROS produced 
by AFB1 exposure [50]. As low as 0.05 ng/ml of AFB1 unregulated the 
production of ROS in polymorphonuclear leukocytes which are at the 
first line of defense against invading bacterial and fungal infections 
[51].
Immune system interference by HCV and role of aflatoxins as 
an immunomodulatory agent
The virus modulates a number of the host cell’s defense processes 
to establish complete infection. Impairment of complement mediated 
pathwayto hinder immune activation and thereby delaying resolution 
of infection was observed [52]. Down regulation of complement 
component C9 in patients as well as in cell culture was observed and 
it was attributed to the core protein of HCV [52]. Using transgenic 
mouse models, it has been observed that nonstructural protein 5A 
(NS5A) of HCV impairs antiviral response and weakens interferon 
immune response along with cytotoxic T lymphocyte response [53].
Numerous studies have attested that AFB1 exposure can affect the 
immune system in a variety of ways. Secretory Immunoglobulin A in 
saliva of Gambian children was noted to be lower when exposed to 
aflatoxin contaminated food [32]. At the same time these mycotoxins 
have led to increased susceptibility to bacterial and parasitic infections 
and adversely affect acquired immunity. Human monocytes when 
exposed to AFB1 in vitro showed reduced microbicidal activity against 
Candida albicans even at low doses of 0.05-0.1 pg/mL. Both decreased 
phagocytosis and decreased secretion of interleukin-1, interleukin-6 
and tumor necrosis factor-alpha were observed [54].
Patients suffering from HIV were tested for aflatoxin exposure 
via aflatoxin-albumin adducts and it was observed that those with 
high aflatoxin-albumin adducts had significantly low T and B cells 
[55]. Hendrickse et al., observed that aflatoxin contaminated-heroin 
addicts showed rapid progression of human immunodeficiency virus 
and acquired immune deficiency syndromes [56]. They attributed 
this accelerated rate of HIV progression to aflatoxin related immune 
suppression. This same synergy can be used to explain the faster rate 
of HIV progression in Africa when compared to Europe or the United 
states where aflatoxin exposure is comparatively controlled. Therefore, 
it is quite possible that accelerated rate of cancer development maybe 
be observed in those HCV patients who are consuming aflatoxin 
contaminated foods.
Conclusions 
In order to improve food quality and to lower the aflatoxin levels 
in food items various practices need to be adopted including effective 
monitoring mechanisms from produce to products, fungal-resistant 
crops. At the consumer level, a change from aflatoxins-susceptible 
diet in highly endemic areas is another possibility. For example, recent 
reforms in China included changing the staple diet from maize to rice 
in the 1980s which actually led to reduced aflatoxin levels in sera and 
ultimately lower primary liver cancer cases [57]. Farmers can opt for 
crops that are resistant to the fungal infection or introduce fungal 
strains that are inefficient in producing aflatoxins. Irrigation techniques 
need to be improved along with drying and storage practices in order to 
keep the moisture content to a minimum. Testing of crops for aflatoxin 
contamination needs to be mandatory and cheap methods of doing so 
are needed. If crops have been contaminated then measures need to 
be introduced for decontamination and detoxification. These include 
food and feed processing, biochemical and microbial inactivation, 
chemical degradation and reduction in toxin bioavailability by 
selective chemisorption with clays. Physical methods may include 
thermal heating but due to toxin being heat stable, this has not been 
successful. Irradiation through radiolysis of water has shown some 
prospect. A last resort is always physical separation of contaminated 
parts by manual, mechanical or electronic means [38]. For example, 
in a study conducted in China, oltipraz, an antischistosomal drug, 
was administered to 234 healthy adults. It was noted that levels of 
aflatoxin m1, which is a phase 1 metabolites of AFB1, were reduced by 
51% in urine samples of individuals receiving a high dose of oltipraz 
[58]. Inclusion of vitamins likes A, C and E in the daily diet could 
also help nullify the toxic effects of aflatoxin exposure to some extent 
[50]. Chlorophyllin, which is a water-soluble derivative of chlorophyll, 
is reported to be anti-mutagenic. When chorophyllin and aflatoxin 
were co-adminitered, this natural product absorbed the toxin before 
it could reach the liver and reduced AFB1-DNA adduct formation 
andhepatocarcinogenesis [59,60]. Although the aforementioned 
preventive measures for lowering aflatoxin levels in foods is necessary 
but until that becomes a reality, perhaps these drugs or vitamins could 
be introduced in areas where aflatoxin consumption is unavoidable in 
order to prevent the development of HCC. 
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